Market Tracker

07/25 4:33am ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

123.74
Delayed Data
As of Jul 24
 +0.69 / +0.56%
Today’s Change
87.50
Today|||52-Week Range
139.79
+21.78%
Year-to-Date

Today’s Trading

Previous close123.05
Today’s open123.35
Day’s range122.07 - 124.70
Volume227,130
Average volume (3 months)218,231
Market cap$2.6B
Dividend yield--
Data as of 07/24/2017

Growth & Valuation

Earnings growth (last year)-101.05%
Earnings growth (this year)+29.21%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+51.53%
P/E ratioNM
Price/Sales19.42
Price/Book7.54

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...-0.11-0.64%
PRTAProthena Corporation...0.000.00%
PBHPrestige Brands Hold...+0.27+0.52%
AGIOAgios Pharmaceutical...+2.21+3.87%
Data as of 07/24/2017

Financials

Next reporting dateAugust 7, 2017
EPS forecast (this quarter)$0.46
Annual revenue (last year)$109.0M
Annual profit (last year)-$2.4M
Net profit margin-2.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
San Diego, California

Forecasts